Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
about
How long does a cough last? Comparing patients' expectations with data from a systematic review of the literatureInfluence of patient symptoms and physical findings on general practitioners' treatment of respiratory tract infections: a direct observation studyPhytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngologyIs Myrtol® Standardized a New Alternative toward Antibiotics?Comprehensive evidence-based review on European antitussivesThe diagnosis and treatment of acute cough in adultsAnti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food-drug pharmacokinetic interaction study in healthy Chinese volunteers.Characterisation of the metabolites of 1,8-cineole transferred into human milk: concentrations and ratio of enantiomers.Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
P2860
Q24605765-6F674A43-E4B4-444A-8574-8681339FA0DFQ24795245-527D7588-C618-46BA-A1D2-7A0871CC6A2CQ27003276-DFED0133-1DFC-4318-863E-88D76A5293EEQ30365812-D9F86D7D-14AC-4428-96E5-E59FBB8BB9DEQ30376142-A89AB377-671D-4FCB-BD77-6A105BE17BC8Q33719165-58EE8987-793D-493D-BF21-C3DB2EF37168Q36464070-45A39907-F94F-47A1-9139-5030DC60D194Q37320807-69A7A472-18E1-439A-B792-7336AC76F736Q37512718-27427BA9-FB1E-43F7-9A79-79A9F72C3FA9Q42362579-8B713CDB-0313-44E7-8141-D96EF525E1A0Q55518623-B241BAB3-9555-4656-950C-BB7F419C2511
P2860
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@ast
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@en
type
label
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@ast
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@en
prefLabel
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@ast
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@en
P2093
P356
P1433
P1476
Efficacy and tolerability of m ...... l vs. cefuroxime and ambroxol.
@en
P2093
P304
P356
10.1055/S-0031-1300276
P577
2000-08-01T00:00:00Z